Arrowhead Pharmaceuticals Inc (ARWR) Common Stock USD0.001
0.64%- This stock can be held in a
Stocks and Shares ISASell:$21.87
Buy:$21.89
Change:
$1.42 (6.10%)
$1.42 (6.10%)Market closed | Prices delayed by at least 15 minutes
Sell:$21.87
Buy:$21.89
Change:$1.42 (6.10%)
$1.42 (6.10%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 April 2024 | James C. HamiltonSenior Vice President | Sell Regular sell transaction (market) | 6,000 | $28.03 | $168,180.00 | 204,851 |
| 20 March 2024 | Hongbo LuDirector | Buy Regular purchase transaction | 1,000 | $27.50 | $27,500.00 | 33,680 |
| 19 March 2024 | Hongbo LuDirector | Buy Regular purchase transaction | 1,000 | $28.00 | $28,000.00 | 32,680 |
| 18 March 2024 | Hongbo LuDirector | Buy Regular purchase transaction | 1,000 | $27.49 | $27,490.00 | 31,680 |
| 6 March 2024 | Kenneth Allen MyszkowskiCFO | Sell Regular sell transaction (market) | 40,000 | $35.19 | $1,407,600.00 | 400,600 |
| 31 January 2024 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 37,769 | $32.16 | $1,214,651.04 | 3,734,778 |
| 31 January 2024 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 19,730 | $32.71 | $645,368.30 | 3,715,048 |
| 12 January 2024 | James C. HamiltonSenior Vice President | Sell Regular sell transaction (market) | 4,238 | $36.47 | $154,559.86 | 214,553 |
| 12 January 2024 | James C. HamiltonSenior Vice President | Sell Regular sell transaction (market) | 3,702 | $37.37 | $138,343.74 | 210,851 |
| 11 January 2024 | Douglass Bruce GivenChairman of the Board | Sell Tax related | 1,811 | $37.76 | $68,383.36 | 130,811 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 May 2023 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 54,928 | $39.14 | $2,149,881.92 | 3,761,338 |
| 6 March 2024 | Kenneth Allen MyszkowskiCFO | Sell Regular sell transaction (market) | 40,000 | $35.19 | $1,407,600.00 | 400,600 |
| 31 January 2024 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 37,769 | $32.16 | $1,214,651.04 | 3,734,778 |
| 4 May 2023 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 25,992 | $40.02 | $1,040,199.84 | 3,761,338 |
| 4 May 2023 | Christopher Richard AnzalonePresident/CEO | Sell Option/Award related | 24,008 | $38.97 | $935,591.76 | 3,787,330 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.